PDA Biosimilars Workshop 2018

The 2018 PDA Biosimilars Workshop will bring together industry experts and regulators to discuss and highlight the strategies required to successfully bring biosimilars to market. The Program Planning Committee, which includes members from industry and the U.S. FDA, has developed the Workshop agenda with a specific focus on the remaining challenges for the development and marketing approval for biosimilars.